Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2005
10/13/2005CA2563038A1 Neurologically-active compounds
10/13/2005CA2562126A1 Pyrazine derivatives and pharmaceutical use thereof
10/13/2005CA2562039A1 Heterocyclic cgrp antagonists for the treatment of migraine
10/13/2005CA2561305A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005CA2560256A1 Heteroaryl piperidine glycine transporter inhibitors
10/13/2005CA2559957A1 Silylated carboxamides
10/13/2005CA2559945A1 Pyrazole compounds and uses related thereto
10/13/2005CA2558915A1 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005CA2557719A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/12/2005EP1584619A1 Derivatives of quinoline as inhibitors for MEK
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583763A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
10/12/2005EP1583758A1 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidine-1-yl)-1h-pyrazol-3-carboxamide, the preparation and therapeutic use thereof
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583742A1 Novel cb 1 receptour inverse agonists
10/12/2005EP1583532A1 Quinoline derivatives as glucokinase ligands
10/12/2005EP1583528A1 Nf-kb inhibitors and uses thereof
10/12/2005EP1583507A2 Magnesium salt of imidazole derivative
10/12/2005EP1242408B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
10/12/2005EP1206466B1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP1177188B1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005EP0912547B1 New substituted pyridyl keto enols
10/12/2005CN1681830A Novel chemical substance having morphogenetic and growth-accelerating activities
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681804A Sulphonamide derivatives and their use as TACE inhibitors
10/12/2005CN1681803A Aroyl-piperidine derivatives
10/12/2005CN1681802A Lansoprazole polymorphs and processes for preparation thereof
10/12/2005CN1681801A Quinolylpropylpiperidine derivatives and their use as anti-microorgans agent
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681793A Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/12/2005CN1681791A 8－羟基喹啉衍生物 8-hydroxyquinoline derivative
10/12/2005CN1681789A 1-pyridin-4-yl-urea derivatives
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681783A 2, 4-substituted indoles and their use as 5-HT6 modulators
10/12/2005CN1681782A 2, 7-substituted indoles and their use as 5-HT6 modulators
10/12/2005CN1681779A 4-pyrrolidino-phenyl-benzyl ether derivatives
10/12/2005CN1681778A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681777A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681504A N-sulfonylpiperidines as metalloproteinase inhibitors (TACE)
10/12/2005CN1681503A Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors
10/12/2005CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors
10/12/2005CN1681501A Novel pyrazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681500A Topical treatment of skin diseases
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680374A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels
10/12/2005CN1680366A Bidentate ligand and its iridium complex and electroluminescent device therewith
10/12/2005CN1680365A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680333A Anti-virus pyrazole derivatives
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680313A Farnesyl transferase inhibitors
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/12/2005CN1679586A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679562A Antiviral compounds
10/12/2005CN1679491A Composition comprising at least one mixed dye based on at least one chromophore of azo or tri(hetero)arylmethane type, dyeing process and mixed dyes
10/12/2005CN1222522C Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use
10/12/2005CN1222514C Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953811 N-substituted tetrahydropyridines and their use as pesticides
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953808 Method for treating gastric disorders using optically pure (−) pantoprazole
10/11/2005US6953807 4-substituted-picolinic acid amide derivatives useful as fungicides
10/11/2005US6953805 Ethyl 6-(((2S)-2-(Ethoxycarbonyl)-4,4-difluoropyrrolidinyl)methyl)-1,2,3,4,4a, 5,6,7,8,8a-decahydroisoquinoline-3-carboxylate, treating migraine pain without attending side effects
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953802 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953793 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953790 CGRP receptor antagonists
10/11/2005US6953789 a 3- or 4-Mercapto-1-(4-phenoxybenzyl)azepine-2-one; thioetherification with a mercaptan; matrix metalloprotease (MMP) inhibitors; antiarthritic, anticaries agent;
10/11/2005US6953788 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2282277C Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092895A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005WO2005092894A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
10/06/2005WO2005092885A1 4-amino-piperidine derivatives as monoamine uptake inhibitors
10/06/2005WO2005092881A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
10/06/2005WO2005092880A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
10/06/2005WO2005092865A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092863A1 4-carbox pyrazole derivates useful as anti-viral agents
10/06/2005WO2005092861A1 Quinolinone derivatives pharmaceutical compositions containing them and their use
10/06/2005WO2005092860A1 Compounds for the treatment of diseases
10/06/2005WO2005092858A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
10/06/2005WO2005092856A1 Tetrahydrocarbazoles and derivatives
10/06/2005WO2005092336A1 Controlled-leaching preparation and process for producing the same
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 1080